Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Non-cash Items: 2014-2024

Historic Non-cash Items for Ocular Therapeutix (OCUL) over the last 11 years, with Dec 2024 value amounting to $11.4 million.

  • Ocular Therapeutix's Non-cash Items rose 239.46% to $11.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.4 million, marking a year-over-year increase of 239.46%. This contributed to the annual value of $11.4 million for FY2024, which is 3.13% up from last year.
  • Per Ocular Therapeutix's latest filing, its Non-cash Items stood at $11.4 million for FY2024, which was up 3.13% from $11.1 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Non-cash Items ranged from a high of $13.3 million in FY2021 and a low of $5.0 million during FY2020.
  • For the 3-year period, Ocular Therapeutix's Non-cash Items averaged around $10.4 million, with its median value being $11.1 million (2023).
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 165.58% in 2021, then plummeted by 35.52% in 2022.
  • Ocular Therapeutix's Non-cash Items (Yearly) stood at $5.0 million in 2020, then surged by 165.58% to $13.3 million in 2021, then crashed by 35.52% to $8.6 million in 2022, then increased by 29.28% to $11.1 million in 2023, then increased by 3.13% to $11.4 million in 2024.